z-logo
open-access-imgOpen Access
Innate Immunity and Inflammation in Temporal Lobe Epilepsy: New Emphasis on the Role of Complement Activation
Author(s) -
Vezzani Annamaria
Publication year - 2008
Publication title -
epilepsy currents
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.415
H-Index - 22
eISSN - 1535-7511
pISSN - 1535-7597
DOI - 10.1111/j.1535-7511.2008.00243.x
Subject(s) - epileptogenesis , complement system , microglia , hippocampal formation , hippocampal sclerosis , temporal lobe , epilepsy , status epilepticus , neuroscience , entorhinal cortex , complement c1q , inflammation , hippocampus , medicine , complement membrane attack complex , biology , immunology , immune system
Aronica E, Boer K, van Vliet EA, Redeker S, Baayen JC, Spliet WG, van Rijen PC, Troost D, da Silva FH, Wadman WJ, Gorter JA. Neurobiol Dis 2007;26(3):497–511. We investigated the involvement of the complement cascade during epileptogenesis in a rat model of temporal lobe epilepsy (TLE), and in the chronic epileptic phase in both experimental as well as human TLE. Previous rat gene expression analysis using microarrays indicated prominent activation of the classical complement pathway which peaked at 1 week after SE in CA3 and entorhinal cortex. Increased expression of C1q, C3 and C4 was confirmed in CA3 tissue using quantitative PCR at 1 day, 1 week and 3–4 months after status epilepticus (SE). Upregulation of C1q and C3d protein expression was confirmed mainly to be present in microglia and in a few hippocampal neurons. In human TLE with hippocampal sclerosis, astroglial, microglial and neuronal (5/8 cases) expression of C1q, C3c and C3d was observed particularly within regions where neuronal cell loss occurs. The membrane attack protein complex (C5b‐C9) was predominantly detected in activated microglial cells. The persistence of complement activation could contribute to a sustained inflammatory response and could destabilize neuronal networks involved.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here